International Journal of Drug Policy

Article	Citations
“It's a revolving door”: Ego-depletion among prisoners with injecting drug use histories as a barrier to post-release success	187
Older age at smoking initiation predicts successful cessation in adults who smoke: A prospective study	114
Evaluating the association between cannabis decriminalization and legalization and cannabis arrests and related disparities: A Systematic review	111
How do restrictions on opioid prescribing, harm reduction, and treatment coverage policies relate to opioid overdose deaths in the United States in 2013–2020? An application of a new state opioid poli	86
Monitoring hepatitis C elimination among people who inject drugs: A broader approach is required	63
Characteristics of supervised injection site clients and factors associated with requiring overdose intervention, Montreal, Canada, 2018–2022	63
Acceptability of hepatitis C testing using point-of-care testing and dried blood spot collection among people at risk of hepatitis C infection	62
International property rights for Cannabis landraces and terroir products. The case of Moroccan Cannabis and hashish	61
Not just fentanyl: Understanding the complexities of the unregulated opioid supply through results from a drug checking service in British Columbia, Canada	59
Response to “COVID-19 economic impact payments and opioid overdose deaths”	59
Investigating opioid preference to inform safe supply services: A cross sectional study	58
A content analysis of cannabis edibles package marketing in the United States	58
Older adults experiences of using recreational cannabis for medicinal purposes following legalization	54
Shifting awareness among electronic dance music party attendees that drugs may contain fentanyl or other adulterants	53
Disruption to Australian heroin, methamphetamine, cocaine and ecstasy markets with the COVID-19 pandemic and associated restrictions	51
Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States	50
Barriers and facilitators of naloxone and safe injection facility interventions to reduce opioid drug-related deaths: A qualitative analysis	50
Influencing the global governance of alcohol: Alcohol industry views in submissions to the WHO consultation for the Alcohol Action Plan 2022-2030	50
The perspectives of people who use drugs regarding short term involuntary substance use care for severe substance use disorders	47
Exploring the role of trauma in underpinning sexualised drug use (‘chemsex’) among gay, bisexual and other men who have sex with men in Singapore	47
Implementing opt-out hepatitis C virus (HCV) screening in Canadian provincial prisons: A model-based cost-effectiveness analysis	46
Simple possession as a ‘tool’: Drug law enforcement practices among police officers in the context of depenalization in British Columbia, Canada	46
Trends in varying modes of drug use in opioid toxicity deaths in Ontario from 2017 to 2021	46
Association between U.S. state prenatal drug use laws and child welfare reporting in Alabama, Maryland and Utah	45
Illicit drug prices and quantity discounts: A comparison between a cryptomarket, social media, and police data	45

There goes the neighborhood? The public safety enhancing effects of a mobile harm reduction intervention	43
Volatile substances are an amorphous category, making it hard to build a comprehensive body of research	42
Controlling for pleasure and risk: The experiences of sexuality and gender diverse people who use GHB	42
The killing of social leaders: An unintended effect of Colombia's illicit crop substitution program	42
Pathways between COVID-19 public health responses and increasing overdose risks: A rapid review and conceptual framework	42
Substances detected in used syringes of injecting drug users across 7 cities in Europe in 2017 and 2018: The European Syringe Collection and Analysis Project Enterprise (ESCAPE)	41
When self-direction meets conformity: Surfacing Schwartz's 10 basic human values in drug policy dialogue with lived/living experience participants	40
Evaluation of the scale-up of HIV testing among people who inject drugs in Scotland in the context of an ongoing HIV outbreak	39
Acceptability of integrating mental health and substance use care within sexual health services among young sexual and gender minority men in Vancouver, Canada	39
Residence in urban or rural counties in relation to opioid overdose mortality among Kentucky hospitalizations before and during the COVID-19 pandemic	39
Evaluating the implementation of a prescription only regulatory model for nicotine vaping products: A qualitative study on the experiences and views of healthcare professionals	37
Drug induced homicide laws may worsen opioid related harms: An example from rural North Carolina	36
The relationship of medical and recreational cannabis laws with opioid misuse and opioid use disorder in the USA: Does it depend on prior history of cannabis use?	36
Editorial Board	36
Harm reduction interventions as a potential solution to managing cannabis use in people with psychosis: A call for a paradigm shift	35
Impact of COVID-19 on the characteristics of opioid overdose deaths in Arkansas	35
Incarceration history, antiretroviral therapy, and stigma: A cross-sectional study of people with HIV who inject drugs in St. Petersburg, Russia	35
Mapping alcohol and tobacco tax policy interventions to inform health and economic impact analyses: A United Kingdom based qualitative framework analysis	34
Homeless women's perspectives on smoking and smoking cessation programs: A qualitative study	34
Disentangling opioids-related overdose syndemics: a scoping review	34
Variation in adults’ use of flavored tobacco products by sales restrictions in California jurisdictions	34
Editorial Board	34
Editorial Board	33
Cognitive enhancing drug use by students in the context of neoliberalism: cheating? Or, a legitimate expression of competitive entrepreneurialism?	33
The Australian ready-to-drink beverages tax missed its target age group	33
COVID-19 and people who use drugs; seizing opportunity in times of chaos	32
Editorial Board	32
Post-Brexit opportunities for tobacco policy reform and tobacco harm reduction in the UK	32
Editorial Board	32
A normalised future of addiction	32
Compliance with a law to reduce alcoholic beverage sales and service in Zacatecas, Mexico	32
Legalization as more effective control? Parallels between the end of alcohol prohibition (1927) and the legalization of cannabis (2018) in Ontario, Canada	32
Editorial Board	31
National increase in the community supply of take‐home naloxone associated with a mass media campaign in Scotland: a segmented time series analysis	31
Editorial Board	31
Opioid prescribing restrictions and opioid use among the Louisiana Medicaid population	31
Taking the potential harms of psychedelic-assisted therapy seriously: How do we prevent or mitigate the risks to vulnerable patients?	31
“No penalties. No arrests. No jails”: Perspectives on drug decriminalization among people who inject drugs in Sydney	29
Early warnings and slow deaths: A sociology of outbreak and overdose	29
Effect of modified income assistance payment schedules on substance use service access: Evidence from an experimental study	28
Generative tension and social risk management surrounding sexualised drug use practice among men who have sex with men in highly stigmatised environments: A qualitative study from Jakarta, Indonesia	28
Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts	28
‘Not just one box that you tick off’ – Deconstructing the hepatitis C care cascade in the interferon-free direct acting antiviral era from the client perspective	28
High HCV cure rates among people who inject drugs and have suboptimal adherence: A patient-centered approach to HCV models of care	28
Socioeconomic stability is associated with lower injection frequency among people with distinct trajectories of injection drug use	27
Publisher's Note	27
Experiences of misuse and symptoms of dependence among people who use gabapentinoids: A qualitative systematic review	27
Can alcohol policy prevent harms to women and children from men's alcohol consumption? An overview of existing literature and suggested ways forward	27
“The missing ‘I’ in drug research and the epistemic justice of disclosure”	27
Policy actor views on structural vulnerability in harm reduction and policymaking for illegal drugs: A qualitative study	27

Neither legal nor illegal: Poppers as ‘acceptable’ chemsex drugs among men who have sex with men in the Philippines	27
Consumption, not decriminalization: How Nigerian drug dealers/users account for cannabis harms	26
Editorial Board	26
The confluence of legacy, corporate social responsibility, and public health: The case of Migros and alcohol-free retailing in Switzerland	26
Carfentanil on the darknet: Potential scam or alarming public health threat?	26
The role of gifts in building influence with politicians: Thematic analysis of interviews with current and former parliamentarians	26
Stigma and self-stigma among women within the context of the german “zero alcohol during pregnancy” recommendation: A qualitative analysis of online forums and blogs	25
Adverse outcomes of GHB use: Analysis of ambulance attendances in metropolitan and regional Victoria	25
Methadone within prison and linkage to and retention in treatment upon community release for people with opioid use disorder in Kyrgyzstan: Evaluation of a national program	25
Quasi-experimental study on the impact of local smoke-free policies on smoking among Indonesian adults: Evidence from repeated national health surveys	25
“Grasping at straws,” experiences of Canadian parents using involuntary stabilization for a youth's substance use	25
Changes in opioid and other analgesic prescribing following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis of early outcomes	25
Identifying how the principles of self-determination could be applied to create effective alcohol policy for First Nations Australians: Synthesising the lessons from the development of general public	25
Public opinion on the expenditure of adult-use cannabis tax revenue: Evidence from New Jersey	25
Between zero risk and harm reduction: An ethnography of Montreal supervised injection services as a public policy instrument	25
Patient perceptions of higher-dose naloxone nasal spray for opioid overdose	25
Leveraging pooled medical examiner records to surveil complex and emerging patterns of polysubstance use in the United States	25
Online surveillance of novel psychoactive substances (NPS): Monitoring Reddit discussions as a predictor of increased NPS-related exposures	25
Deal or no-deal? Using administrative data to explore buyer motivation in online drug purchases and its association with community risk factors in Scotland	24
What's in Stock? Drug drought anticipation during COVID-19 among people who use drugs and service providers	24
Assessing options for poppers policy in Canada: A call to action for evidence-based policy reform	24
City streetscapes and neighborhood characteristics of fatal opioid overdoses among people experiencing homelessness who use drugs in New York City, 2017–2019	24
Drug use before and during imprisonment: Drivers of continuation	24
Identifying barriers and enablers to opt-out hepatitis C virus screening in provincial prisons in Quebec, Canada: A multilevel, multi-theory informed qualitative study with correctional and healthcare	24
Uncertainty and risk: A framework for understanding pricing in online drug markets	24
Drug policy goals in a changing landscape: Perspectives of practitioners in Japan	24
A mixed methods study to inform fatal overdose prevention in San Diego, California: Perspectives from people who use drugs	23
“We were all looking for the magic pill”: A qualitative study of patient experiences using gabapentinoids for chronic pain	23
Treating addiction with deep brain stimulation: Ethical and legal considerations	23
Caring for coca, living with chemicals: Towards ecological harm reduction	23
Civil commitment perspectives and experiences among friends and family of people who use illicit opioids in Massachusetts, USA	23
Prospective association of interventions for at-risk families with illicit drug use among young students in Taiwan	23
“It's professional but it's personal”: Participation, personal connection, and sustained disagreement in drug policy reform	23
How Covid-19 restrictions affected young people's well-being and drinking practices: Analyzing interviews with a socio-material approach	23
The effects of the 4/20 cannabis holiday and adult-use cannabis legalization on medical cannabis sales and medical cannabis patient registration in Arizona	23
Publics in local media reporting on harm reduction: Rightfully worried local witnesses or uneducated obstacles to change	23
The adoption and sustainability of digital therapeutics in justice systems: A pilot feasibility study	23
‘Some days I am a lunatic that thinks I can moderate’: Amalgamating recovery and neo-liberal discourses within accounts of non-drinking among women active in the ‘positive sobriety’ community on Insta	23
How is alcohol consumption and heavy episodic drinking spread across different types of drinking occasion in Great Britain: An event-level latent class analysis	22
“You rise up and then you start pulling people up with you”: Patient experiences with a peer-delivered behavioral activation intervention to support methadone treatment	22
Waiting for inpatient detoxification: A qualitative analysis of patient experiences	22
Integrated biobehavioral surveillance among people who inject drugs in Ukraine, 2007-2020	22
Smuggling of drugs by body packing: Evidence from Chinese sentencing documents	22
Development of a systematic social observation tool for monitoring use of harm reduction supplies	22
“It gets you high as a kite but not unsick”: Characterizations of and responses to a changing local drug supply by people who use drugs in Rhode Island	22
Doing more with less: A proposal to advance cigarette packaging regulations in the United States	22
Social-spatial network structures among young urban and suburban persons who inject drugs in a large metropolitan area	22
I don't even want to go to the doctor when I get sick now: Healthcare experiences and discrimination reported by people who use drugs, Arizona 2019	22
Patient and healthcare provider perceptions of acceptability of fingerstick point-of-care hepatitis C testing at Aboriginal Community Controlled Health Services in Australia	22
Factors associated with receipt of medication for opioid use disorder among pregnant individuals entering treatment programs in the U.S.	22
Tinkering with care: Implementing extended-release buprenorphine depot treatment for opioid dependence	22
Defining a public health approach to substance use: Perspectives from professionals and practitioners across Canada	21
Enhancement motivations for using prescription drugs among young adults in Nigeria	21
Virtual raves and happy hours during COVID-19: New drug use contexts for electronic dance music partygoers	21
Evaluating trends and stakeholders in the international drug control regime complex	21
20-year trends in Australian methamphetamine-related deaths, 2001–2020	21
Simulated impact of medicaid expansion on the economic burden of opioid use disorder in North Carolina	21
Decision-making by laypersons equipped with an emergency response smartphone app for opioid overdose	20
Testing the boundaries: Self-medicated testosterone replacement and why it is practised	20
Socio-ecological and pharmacy-level factors associated with buprenorphine stocking at pharmacies in New York City	20
High and highly bonded: Fused football fans who use cocaine are most likely to be aggressive toward rivals	20
Non-medical cannabis use among Indigenous Canadians: A systematic review of prevalence and associated factors	20
High occurrence of witnessing an opioid overdose in a sample of women who use heroin in Tanzania: Implications for overdose prevention	20
Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada	20
Legacies of the war on drugs: Next of kin of persons who died of opioid overdose and harm reduction interventions in Philadelphia	20
Hepatitis C treatment at a Swedish needle exchange program, a successful model of care – the ACTIONNE study	19
Comparing characteristics and outcomes of different opioid agonist treatment modalities among opioid-dependent federal men correctional populations in Canada	19
Structural violence and necropolitics among Indigenous Peoples living with HIV who use substances in the Prairie provinces during COVID-19	19
Cannabis policies in Canada: How will we know which is best?	19
Analysis of gaps in alcohol policies in Brazil using the Pan American Health Organization's Alcohol Policy Scoring	19
Simulating the impact of Addiction Consult Services in the context of drug supply contamination, hospitalizations, and drug-related mortality	19
U.S. state policies on opioid prescribing during the peak of the prescription opioid crisis: Associations with opioid overdose mortality	19
A matter of craving–An archeology of relapse prevention in Swedish addiction treatment	19
‘I just drink to feel abnormal for some time’: Reconfiguring heavy drinking and intoxication as pleasurable	19
Non-prescription drug use among HIV positive gay and bisexual men in Australia: A latent class analysis and comparison of health and well-being	19
Using nominal group technique with people who are incarcerated in Canadian federal prisons to identify barriers and solutions to improving Prison Needle Exchange Program uptake	19
Understanding challenges for recovery homes during COVID-19	18
Alignment in local approaches to alcohol and cannabis control policy: A case study of California cities and counties	18
Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a ‘moral hazard’ associated with naloxone supply	18
How much demand for money laundering services does drug selling create? Identifying the key parameters	18

Rethinking enhancement substance use: A critical discourse studies approach	18
Conceptualising retention in treatment with long-acting injectable buprenorphine (for opioid use disorder) as a journey: Findings from a longitudinal qualitative study	18
Optimizing the impact of medications for opioid use disorder at release from prison and jail settings: A microsimulation modeling study	18
Social disparities in alcohol's harm to others: evidence from 32 European countries	18
Direct democracy and the adoption of recreational marijuana legalization in the United States, 2012–2019	18
Opioid and polydrug use among rural sexual and gender minorities: Current knowledge and future directions	18
Visitors of the Dutch drug checking services: Profile and drug use experience	18
Unpacking the differing understandings of “alcohol industry” in public health research	18
“Keeping your composure”: A digital ethnography of gendered alcohol norms on Instagram	17
Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey	17
Tracing a path for opium gum from Mexico as a safe supply harm reduction measure for Canada	17
‘Choice’ of social media platform or encrypted messaging app to buy and sell illegal drugs	17
Impact of the COVID-19 pandemic on cannabis cultivation and use in 18 countries	17
Editorial Board	17
A systematic review and meta-analysis of the prevalence of take-home naloxone (THN) ownership and carriage	17
Corrigendum to ‘Uncertainty and risk: A framework for understanding pricing in online drug markets’ [International Journal of Drug Policy 101 (2022) 1–13]	17
Practising recovery: New approaches and directions	17
Modeling the impact of a supervised consumption site on HIV and HCV transmission among people who inject drugs in three counties in California, USA	17
Race, cannabis and the Canadian war on drugs: An examination of cannabis arrest data by race in five cities	17
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study	17
“You can't go wrong being safe”: Motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs	16
Framework for opioid use disorder screening and diagnosis in carceral settings	16
Bridging the gap: An environmental scan of post-overdose program features and evaluation measures	16
Good Samaritan laws and overdose mortality in the United States in the fentanyl era	16
Education as drug policy: A realist synthesis of continuing professional development for opioid agonist therapy	16
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis	16
The police paradox: A qualitative study of post-overdose outreach program implementation through public health-public safety partnerships in Massachusetts	16
Opioid agonist treatment programs and hepatitis C virus elimination in Taiwan: Ways of expanding the care cascade in screening and treatment	16
Women and opioid use disorder treatment: A scoping review of experiences, use of patient-reported experience measures, and integration of person-centred care principles	16
Co-designing the INHSU Prisons Hepatitis C Advocacy Toolkit using the Advocacy Strategy Framework	16
The United Kingdom's first unsanctioned overdose prevention site; A proof-of-concept evaluation	16
Deadly serious: The United Nations, drugs, and capital punishment in the 1980s	16
Endocarditis, drug use and biological sex: A statewide analysis comparing sex differences in drug use-associated infective endocarditis with other drug-related harms	16
“Tethered to this ball and chain”: Women's perspectives on bodily agency within opioid treatment programs	16
Frequency is not enough: Characterizing heterogenous patterns of cannabis use intensity among reservation-area American Indian youth	16
High hepatitis C virus reinfection in a community-based sample of people who inject drugs in Imphal, India	16
Stimulant use interventions may strengthen ‘Getting to Zero’ HIV elimination initiatives in Illinois: Insights from a modeling study	16
Privacy and confidentiality in Massachusetts' post-overdose outreach programs: Mixed methods analysis of outreach staff surveys and interviews	15
Increased solitary drug use during COVID-19: An unintended consequence of social distancing	15
Trends in the use of cannabis products in Canada and the USA, 2018 – 2020: Findings from the International Cannabis Policy Study	15
A mixed methods study of provider factors in buprenorphine treatment retention	15
Factors associated with drug use in prison: A systematic review of quantitative and qualitative evidence	15
Factors associated with 60-day adherence to “safer supply” opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during COVID-	15
Economic analysis of out-of-pocket costs among people in opioid agonist treatment: A cross-sectional survey in three Australian jurisdictions	15
Lay knowledge and practices of methamphetamine use to manage opioid-related overdose risks	15
Opioid agonist therapy engagement and crystal methamphetamine use: The impact of unregulated opioid use in Vancouver, Canada	15
A population-based study on the risk of prescription opioid abuse in patients with chronic opioid use and cost-effectiveness of prescription drug monitoring program using a patient simulation model in	15
Perceived social support moderates the association between household dysfunction adverse childhood experiences (ACEs) and self-reported drug use among men who have sex with men in Los Angeles, Califor	14
Recreational drug use and use of drugs associated with chemsex among HIV-negative and HIV-positive heterosexual men and women attending sexual health and HIV clinics in England	14
National and regional trends in fentanyl seizures in the United States, 2017–2023	14
Interventions to prevent HIV and Hepatitis C among people who inject drugs: Latest evidence of effectiveness from a systematic review (2011 to 2020)	14
The introduction of fentanyl on the US–Mexico border: An ethnographic account triangulated with drug checking data from Tijuana	14
Substance use among pregnant women in NSW prisons	14
‘Alternative facts’: Public opinion surveys on the death penalty for drug offences in selected Asian countries	14
Beyond struggle: A strengths-based qualitative study of cannabis use among queer and trans youth in Québec	14
The social-structural contexts of cannabis consumption and harm reduction among young Nigerian women	14
More than just ‘free heroin’: Caring whilst navigating constraint in the delivery of diamorphine assisted treatment	14
Effect of incarceration and opioid agonist treatment transitions on risk of hospitalisation with injection drug use-associated bacterial infections: A self-controlled case series in New South Wales, A	14
Peer-delivered point-of-care testing and linkage to treatment for hepatitis C virus infection among marginalized populations through a mobile clinic in Copenhagen, Denmark	14
Interventions to increase linkage to care and adherence to treatment for hepatitis C among people who inject drugs: A systematic review and practical considerations from an expert panel consultation	14
“Everybody is impacted. Everybody's hurting”: Grief, loss and the emotional impacts of overdose on harm reduction workers	14
Naloxone expansion is not associated with increases in adolescent heroin use and injection drug use: Evidence from 44 US states	13
A qualitative comparison of how people who use drugs’ perceptions and experiences of policing affect supervised consumption services access in two cities	13
This is your brain on drug education: Putting young people with lived experience at the center of drug education	13
Enhancing equity-oriented care in psychedelic medicine: Utilizing the EQUIP framework	13
How risky are heroin markets? A multi-site study of self-reported risk perceptions among police detainees in Australia	13
Manifest your desires: Psychedelics and the self-help industry	13
What are the harms of vaping in young people who have never smoked?	13
Characterizing stimulant overdose: A qualitative study on perceptions and experiences of “overamping”	13
Factors associated with opioid-involved overdose among previously incarcerated people in the U.S.: A community engaged narrative review	13
Coordination, cooperation, and creativity within harm reduction networks in Iran: COVID-19 prevention and control among people who use drugs	13
The effectiveness of smoking cessation interventions in rural and remote populations: Systematic review and meta-analyses	13
Creativity, care and ‘messy’ drug use: A collective history of the early days of peer-led needle exchange in Dunedin, New Zealand	13
It is time for us all to embrace person-centred language for people in prison and people who were formerly in prison	13
Ancient psychoactive plants in a global village: The ritual use of cannabis in a self-managed community in Catalonia	13
Towards equity for people who inject drugs in HIV prevention drug trials	13
From Anti-doping-I to Anti-doping-II: Toward a paradigm shift for doping prevention in sport	13
Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers	13
‘Red Flags’ and ‘Red Tape’: Telehealth and pharmacy-level barriers to buprenorphine in the United States	13
COVID-19 risks among people who inject drugs in Puerto Rico	13
Cannabis edibles packaging: Communicative objects in a growing market	13
The war on drugs in Southeast Asia as ‘state vigilantism’	13
Long-term patterns of treatment use for opioid use disorder (OUD): Findings from the 18-20-year Australian Treatment Outcome Study	13
‘What makes up wine o'clock? Understanding social practices involved in alcohol use among women aged 40–65 years in Australia	13
Addressing the complex substance use and mental health needs of people leaving prison: Insights from developing a national inventory of services in Canada	12
High willingness to use drug consumption rooms among people who inject drugs in Scotland: findings from a national bio-behavioural survey among people who inject drugs	12
Using nominal group technique to identify perceived barriers and facilitators to improving uptake of the Prison Needle Exchange Program in Canadian federal prisons by correctional officers and healthc	12
The effects of race and class on community-level stigmatization of opioid use and policy preferences	12
Financial incentives to increase engagement across the hepatitis C care cascade among people at risk of or diagnosed with hepatitis C: A systematic review	12
Reprint of: The regulation project: Tools for engaging the public in the legal regulation of drugs	12
Development and validation of the Substance Use Protective Strategies Scale (SUPSS) among Polish young adults using various psychoactive substances	12
Historic and current achievements of the temperance movement in the control of alcohol and its adverse health consequences	12
Hospital policy as a harm reduction intervention for people who use drugs	12
Examining reactions to smoking and COVID-19 risk messages: An experimental study with people who smoke	12
Decriminalization thresholds for drug possession: A multi-criteria policy analysis framework	12